Sheela Kolluri

2.0k total citations
27 papers, 1.5k citations indexed

About

Sheela Kolluri is a scholar working on Psychiatry and Mental health, Pharmacology and Rheumatology. According to data from OpenAlex, Sheela Kolluri has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 5 papers in Rheumatology. Recurrent topics in Sheela Kolluri's work include Schizophrenia research and treatment (10 papers), Bipolar Disorder and Treatment (5 papers) and Treatment of Major Depression (5 papers). Sheela Kolluri is often cited by papers focused on Schizophrenia research and treatment (10 papers), Bipolar Disorder and Treatment (5 papers) and Treatment of Major Depression (5 papers). Sheela Kolluri collaborates with scholars based in United States, New Zealand and United Kingdom. Sheela Kolluri's co-authors include Kenneth G. Saag, Jaren W. Landen, Frank S. Menniti, Michael Krams, Bryan Baker, Sheldon Preskorn, Gary W. Hunninghake, James R. Cerhan, Kenjirou Ohashi and David A. Schwartz and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Psychiatry and Annals of the Rheumatic Diseases.

In The Last Decade

Sheela Kolluri

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheela Kolluri United States 15 441 349 341 328 273 27 1.5k
Nina Mononen Finland 30 206 0.5× 176 0.5× 163 0.5× 56 0.2× 232 0.8× 88 2.4k
Riikka Rontu Finland 25 143 0.3× 201 0.6× 147 0.4× 38 0.1× 234 0.9× 62 1.7k
Jennifer R. Cracchiolo United States 20 198 0.4× 285 0.8× 166 0.5× 44 0.1× 121 0.4× 84 2.0k
Ian C. Wilson United States 26 222 0.5× 486 1.4× 110 0.3× 24 0.1× 302 1.1× 56 2.1k
David D. Ørsted Denmark 20 292 0.7× 41 0.1× 394 1.2× 47 0.1× 158 0.6× 32 2.4k
C. Kirkegaard Denmark 27 140 0.3× 180 0.5× 244 0.7× 37 0.1× 236 0.9× 101 2.2k
Sandra Barral United States 19 182 0.4× 166 0.5× 129 0.4× 72 0.2× 123 0.5× 43 1.3k
Rona J. Strawbridge Sweden 24 115 0.3× 91 0.3× 107 0.3× 61 0.2× 269 1.0× 83 2.0k
Nobuto Shibata Japan 21 104 0.2× 183 0.5× 190 0.6× 83 0.3× 251 0.9× 101 1.6k
Anne Börjesson‐Hanson Sweden 22 113 0.3× 66 0.2× 97 0.3× 65 0.2× 477 1.7× 40 1.2k

Countries citing papers authored by Sheela Kolluri

Since Specialization
Citations

This map shows the geographic impact of Sheela Kolluri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheela Kolluri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheela Kolluri more than expected).

Fields of papers citing papers by Sheela Kolluri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheela Kolluri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheela Kolluri. The network helps show where Sheela Kolluri may publish in the future.

Co-authorship network of co-authors of Sheela Kolluri

This figure shows the co-authorship network connecting the top 25 collaborators of Sheela Kolluri. A scholar is included among the top collaborators of Sheela Kolluri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheela Kolluri. Sheela Kolluri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conrado, Daniela J., Sriram Krishnaswami, Satoshi Shoji, et al.. (2016). Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose–response analysis. Journal of Pharmacokinetics and Pharmacodynamics. 43(3). 325–341. 17 indexed citations
2.
Buttgereit, Frank, Vibeke Strand, Dorothy McCabe, et al.. (2015). SAT0221 Efficacy and Safety of PF-04171327, a Novel Dissociated Agonist of the Glucocorticoid Receptor (DAGR): Results of a Phase 2, Randomized, Double-Blind Study. Annals of the Rheumatic Diseases. 74. 737–738. 5 indexed citations
3.
Fleischhacker, W. Wolfgang, John M. Kane, Jamie Geier, et al.. (2014). Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial. The Journal of Clinical Psychiatry. 75(3). e184–e190. 41 indexed citations
4.
Maurer, Matthew J., Arnt V. Kristen, Claudio Rapezzi, et al.. (2013). CARDIAC BIOMARKERS IN PATIENTS WITH TRANSTHYRETIN AMYLOIDOSIS AS DOCUMENTED IN THAOS: THE TRANSTHYRETIN AMYLOIDOSIS SURVEY. Journal of the American College of Cardiology. 61(10). E1244–E1244. 4 indexed citations
5.
Perlis, Roy H., et al.. (2012). Adjunctive Oral Ziprasidone in Patients With Acute Mania Treated With Lithium or Divalproex, Part 2. The Journal of Clinical Psychiatry. 73(11). 1420–1425. 9 indexed citations
6.
Camm, A. John, Onur N. Karayal, Herbert Y. Meltzer, et al.. (2012). Ziprasidone and the Corrected QT Interval. CNS Drugs. 26(4). 351–365. 28 indexed citations
7.
Pappadopulos, Elizabeth, John W. Newcomer, & Sheela Kolluri. (2012). Changes in Weight, Plasma Lipids, and Glucose in Adults Treated With Ziprasidone. The Journal of Clinical Psychiatry. 73(6). e742–e748. 12 indexed citations
8.
Perlis, Roy H., et al.. (2012). Adjunctive Oral Ziprasidone in Patients With Acute Mania Treated With Lithium or Divalproex, Part 1. The Journal of Clinical Psychiatry. 73(11). 1412–1419. 15 indexed citations
9.
Lombardo, Ilise, Gary Sachs, Sheela Kolluri, C.M.E. Kremer, & Ruoyong Yang. (2012). Two 6-Week, Randomized, Double-Blind, Placebo-Controlled Studies of Ziprasidone in Outpatients With Bipolar I Depression. Journal of Clinical Psychopharmacology. 32(4). 470–478. 48 indexed citations
10.
Karayal, Onur N., Paul Glue, Michelle Stewart, et al.. (2011). Switching from Quetiapine to Ziprasidone. Journal of Psychiatric Practice. 17(2). 100–109. 14 indexed citations
11.
Geier, Jamie, Onur N. Karayal, Michael D. Lewis, et al.. (2011). Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow‐up: the ziprasidone observational study of cardiac outcomes (ZODIAC). Pharmacoepidemiology and Drug Safety. 20(11). 1192–1198. 7 indexed citations
12.
Glue, Paul, et al.. (2009). Comparative efficacy of antidepressants in preventing relapse in anxiety disorders — A meta-analysis. Journal of Affective Disorders. 123(1-3). 9–16. 40 indexed citations
13.
Preskorn, Sheldon, Bryan Baker, Sheela Kolluri, et al.. (2008). An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder. Journal of Clinical Psychopharmacology. 28(6). 631–637. 422 indexed citations
14.
Binneman, Brendon, et al.. (2008). A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH 1 Antagonist) in the Treatment of Major Depression. American Journal of Psychiatry. 165(5). 617–620. 185 indexed citations
15.
Eaton, Morris L., Robb J. Muirhead, Jessica Mancuso, & Sheela Kolluri. (2006). A Confidence Interval for the Maximal Mean QT Interval Change Caused by Drug Effect. Drug Information Journal. 40(3). 267–271. 17 indexed citations
16.
Fisher, Jeannine M., Ann E. Taylor, Sheela Kolluri, et al.. (2005). Effects of Steady-State Lasofoxifene on Cyp2D6- and Cyp2E1-Mediated Metabolism. Annals of Pharmacotherapy. 40(1). 32–37. 10 indexed citations
17.
Saag, Kenneth G., et al.. (1998). Arthritis health service utilization among the elderly: The role of urban‐rural residence and other utilization factors. Arthritis & Rheumatism. 11(3). 177–185. 27 indexed citations
18.
Saag, Kenneth G., Bradley N. Doebbeling, James E. Rohrer, et al.. (1998). Variation in Tertiary Prevention and Health Service Utilization Among the Elderly. Medical Care. 36(7). 965–976. 25 indexed citations
19.
Saag, Kenneth G., et al.. (1996). Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis & Rheumatism. 39(10). 1711–1719. 170 indexed citations
20.
Saag, Kenneth G., et al.. (1996). Low‐dose corticosteroids in rheumatoid arthritis. A meta‐analysis of their moderate‐term effectiveness. Arthritis & Rheumatism. 39(11). 1818–1825. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026